The current study found for the first time that both the mRNA expression and protein expression of DBT were downregulated in ccRCC, and were also verified in many renal cancer cell lines and in renal clear cell carcinoma tissues from our study centre. The gene discussed is DBT; the disease is nonpapillary renal cell carcinoma.